Patents by Inventor Christopher Don Roberts

Christopher Don Roberts has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8729077
    Abstract: Disclosed are compounds, stereoisomers, tautomers, or pharmaceutically acceptable salts thereof, their preparation, use, and compositions thereof for treating an infection mediated at least in part by a virus in the Flaviviridae family of viruses.
    Type: Grant
    Filed: November 19, 2009
    Date of Patent: May 20, 2014
    Assignee: GlaxoSmithKline LLC
    Inventors: Frank Ulrich Schmitz, Roopa Rai, Christopher Don Roberts, Wieslaw Kazmierski, Richard Grimes
  • Publication number: 20120121540
    Abstract: Provided are certain chemical entities, pharmaceutical compositions, and methods of treatment of a member of the flaviviradae family of viruses such as hepacivirus (Hepatitis C or HCV).
    Type: Application
    Filed: August 8, 2008
    Publication date: May 17, 2012
    Inventors: Franz Ulrich Schmitz, Vincent W.F Tai, Roopa Ral, Christopher Don Roberts, Ali Dehghani Mohammad Abadi, Subramanian Baskaran, Irina Slobodov, Jack Maung, Martin Leon Neitzel
  • Publication number: 20100061960
    Abstract: Disclosed are compounds, stereoisomers, tautomers, or pharmaceutically acceptable salts thereof, their preparation, use, and compositions thereof for treating an infection mediated at least in part by a virus in the Flaviviridae family of viruses.
    Type: Application
    Filed: July 16, 2009
    Publication date: March 11, 2010
    Inventors: Franz Ulrich Schmitz, Roopa Rai, Ronald Griffith, Christopher Don Roberts
  • Publication number: 20100055071
    Abstract: Disclosed are compounds, stereoisomers, tautomers, pharmaceutically acceptable salts, or prodrugs thereof of having Formula (I), their preparation, use, and compositions thereof for treating an infection mediated at least in part by a virus in the Flaviviridae family of viruses, wherein A, L1, V, W, T, Z, R, Y1, and p are as defined herein.
    Type: Application
    Filed: November 20, 2007
    Publication date: March 4, 2010
    Inventors: Martin Robert Leivers, Franz Ulrich Schmitz, Christopher Don Roberts, Ali Dehghani Mohammad Abadi
  • Publication number: 20100004441
    Abstract: Disclosed are compounds having Formula (I) and the compositions and methods thereof for treating or preventing a viral infection mediated at least in part by a virus in the Flaviviridae family of viruses, wherein A, R2, m, R, V, W, T, Z, R1, Y, and p are disclosed herein.
    Type: Application
    Filed: August 20, 2009
    Publication date: January 7, 2010
    Inventors: Franz Ulrich Schmitz, Christopher Don Roberts, Ali Dehghani Mohammad Abadi, Ronald Conrad Griffith, Martin Robert Leivers, Irina Slobodov, Roopa Rai
  • Publication number: 20090317360
    Abstract: Disclosed are compounds and compositions of Formula (I), pharmaceutically acceptable salts and solvates thereof, and their uses for treating viral infections mediated at least in part by a virus in the Flaviviridae family of viruses.
    Type: Application
    Filed: June 11, 2008
    Publication date: December 24, 2009
    Inventors: Roopa Rai, Franz Ulrich Schmitz, Christopher Don Roberts, Irina Slobodov, Martin Robert Leivers
  • Patent number: 7629340
    Abstract: Disclosed are compounds having Formula (I) and the compositions and methods relating to these compounds, for treating or preventing a viral infection mediated at least in part by a virus in the Flaviviridae family of viruses, wherein A, R2, m, R, V, W, T, Z, R1, Y, and p are disclosed herein.
    Type: Grant
    Filed: December 12, 2006
    Date of Patent: December 8, 2009
    Assignee: SmithKline Beecham Corporation
    Inventors: Franz Ulrich Schmitz, Christopher Don Roberts, Ali Dehghani Mohammad Abadi, Ronald Conrad Griffith, Martin Robert Leivers
  • Publication number: 20090253648
    Abstract: Disclosed are compounds represented by formulae I, II, and III, and the compositions and methods thereof for treating viral infections caused by a Flaviviridae family virus.
    Type: Application
    Filed: March 31, 2009
    Publication date: October 8, 2009
    Applicant: SMITHKLINE BEECHAM CORPORATION
    Inventors: Jesse Daniel Keicher, Christopher Don Roberts, Sebastian Johannes Reinhard Liehr, Xiaoling Zheng, Marija Prhavc, Vivek Kumar Rajwanshi, Ronald Conrad Griffith, Choung U. Kim
  • Patent number: 7595398
    Abstract: Disclosed are compounds having Formula (I) and the compositions and methods thereof for treating or preventing a viral infection mediated at least in part by a virus in the Flaviviridae family of viruses, wherein A, R2, m, R, V, W, T, Z, R1, Y, and p are disclosed herein.
    Type: Grant
    Filed: December 12, 2006
    Date of Patent: September 29, 2009
    Assignee: SmithKline Beecham Corporation
    Inventors: Franz Ulrich Schmitz, Christopher Don Roberts, Ali Dehghani Mohammad Abadi, Ronald Conrad Griffith, Martin Robert Leivers, Irina Slobodov, Roopa Rai
  • Publication number: 20090226398
    Abstract: Disclosed are compounds and compositions of Formula (I), pharmaceutically acceptable salts and solvates thereof, and their preparation and uses for treating viral infections mediated at least in part by a virus in the Flaviviridae family of viruses.
    Type: Application
    Filed: March 3, 2009
    Publication date: September 10, 2009
    Inventors: Martin Robert Leivers, Christopher Don Roberts, Sebastian Johannes Reinhard Liehr, Stephanie Anna Chan, Roopa Rai, Ryan Lauchli, Son Minh Pham, Vivek Kumar Rajwanshi, Tony Loc Ton, Adam Christopher Villa
  • Publication number: 20090208457
    Abstract: Disclosed are compounds, compositions and methods for treating viral infections caused by a Flaviviridae family virus, such as hepatitis C virus.
    Type: Application
    Filed: March 31, 2009
    Publication date: August 20, 2009
    Applicant: SMITHKLINE BEECHAM CORPORATION
    Inventors: Jesse Daniel Keicher, Christopher Don Roberts
  • Publication number: 20090197856
    Abstract: Provided are compounds of Formula (I) or a pharmaceutically acceptable salt or solvate thereof. The compounds and compositions are useful for treating viral infections caused by the Flaviviridae family of viruses.
    Type: Application
    Filed: December 19, 2008
    Publication date: August 6, 2009
    Inventors: Salvador G. Alvarez, Janos Botyanszki, Joseph de los Angeles, Jiping Fu, Roger Fujimoto, Joshua Michael Gralapp, Ronald Conrad Griffith, Peichao Lu, Son Minh Pham, Christopher Don Roberts, Franz Ulrich Schmitz, Mohindra Seepersaud, Ruben Tommasi, Adam Christopher Villa, Sompong Wattanasin, Aregahagn Yifru, Rui Zheng, Xiaoling Zheng
  • Publication number: 20090176778
    Abstract: Provided are certain chemical entities, pharmaceutical compositions, and methods of treatment of a member of the flaviviradae family of viruses such as hepacivirus (Hepatitis C or HCV).
    Type: Application
    Filed: August 8, 2008
    Publication date: July 9, 2009
    Inventors: Franz Ulrich Schmitz, Vincent W-F Tai, Roopa Rai, Christopher Don Roberts, Ali Dehghani Mohammad Abadi, Subramanian Baskaran, Irina Slobodov, Jack Maung, Martin Leon Neitzel
  • Patent number: 7534771
    Abstract: Disclosed are compounds, compositions and methods for treating viral infections caused by a Flaviviridae family virus, such as hepatitis C virus.
    Type: Grant
    Filed: February 28, 2006
    Date of Patent: May 19, 2009
    Assignee: SmithKline Beecham Corporation
    Inventors: Jesse Daniel Keicher, Christopher Don Roberts
  • Patent number: 7511145
    Abstract: Disclosed are compounds, compositions and methods for treating Flaviviridae family virus infections.
    Type: Grant
    Filed: July 30, 2004
    Date of Patent: March 31, 2009
    Assignee: Genelabs Technologies, Inc.
    Inventors: Franz Ulrich Schmitz, Christopher Don Roberts, Ronald Conrad Griffith, Janos Botyanszki, Mikail Hakan Gezginci, Joshua Michael Gralapp, Dong-Fang Shi, Sebastian Johannes Reinhard Liehr
  • Publication number: 20090081165
    Abstract: Disclosed are compounds, compositions and methods for treating Flaviviridae family virus infections.
    Type: Application
    Filed: October 30, 2008
    Publication date: March 26, 2009
    Inventors: Franz Ulrich Schmitz, Christopher Don Roberts, Ronald Conrad Griffith, Janos Botyanszki, Mikail Hakan Gezginci, Joshua Michael Gralapp, Dong-Fang Shi, Sebastian Johannes Reinhard Liehr
  • Publication number: 20090062223
    Abstract: Provided are compounds of Formula (I) or a pharmaceutically acceptable salt or solvate thereof. The compounds and compositions are useful for treating viral infections caused by the Flaviviridae family of viruses.
    Type: Application
    Filed: August 29, 2008
    Publication date: March 5, 2009
    Inventors: Jesse Daniel Keicher, Christopher Don Roberts, Vivek Kumar Rajwanshi, Ronald Conrad Griffith, Xiaoling Zheng, Sebastian Johannes Reinhard Liehr, Marija Prhavc, Choung U. Kim, Adrian S. Ray
  • Publication number: 20090048189
    Abstract: Disclosed are tricyclic nucleoside compounds of formula (I), and methods thereof for treating viral infections mediated at least in part by a Flaviviridae family virus.
    Type: Application
    Filed: August 15, 2007
    Publication date: February 19, 2009
    Inventors: Jesse Daniel KEICHER, Christopher Don Roberts, Sebastian Johannes Reinhard Liehr, Xiaoling Zheng, Marija Prhavc, Vivek Kumar Rajwanshi, Ronald Conrad Griffith, Choung U. Kim
  • Publication number: 20080249060
    Abstract: Disclosed are compounds, compositions and methods for treating hepatitis C virus infections.
    Type: Application
    Filed: May 19, 2008
    Publication date: October 9, 2008
    Inventors: Christopher Don Roberts, Natalia B. Dyatkina
  • Patent number: 7425547
    Abstract: Disclosed are compounds, compositions and methods for treating viral infections caused by a flaviviridae family virus, such as hepatitis C virus. Such compounds are represented by Formula IB as follows: and pharmaceutically acceptable prodrugs and salts thereof, where R, R1, R13, R14, W, W2, W3, Y and Z are as defined herein.
    Type: Grant
    Filed: September 30, 2003
    Date of Patent: September 16, 2008
    Assignee: Genelabs Technologies, Inc.
    Inventors: Christopher Don Roberts, Natalia B. Dyatkina